News & Articles

Venture Technology Group Announces Collaborative Partnership with Ingrid Vickery, Principal, Artelier Brand Development & Communications We are thrilled to welcome Ingrid Vickery, Principal and Senior Strategist of Artelier Brand Development & Communications,...

The requirements of COVID-19 containment and isolation have had a profound effect on all aspects of community life in 2020 and beyond. What has the impact been on clinical trials in Australia? Feedback from the market indicates that clinical trials activities were up...

Venture Technology Group Announces Collaborative Partnership with Mr Matt McCarthy, Manager, Global Investment and Innovation Incentives (Gi3) at Deloitte Dr Dennis Feeney, Founder and Chair of Venture Technology Group (VTG) and VTG Search is pleased to announce...

There are numerous opportunities that can be pursued by the Australian sector in a global market: A Strong international reputation for quality; Diverse culture, social-economic stability and unique safe location; An equitable healthcare system; A strong research...

Emerging Australian Neuroscience Company Snoretox Wins $1 million in Medical Research Future Fund (MRFF) funding and a pathway towards a further $50 million of funding over the next five years. In a world-first in the development of treatments for lax muscle tone and...